Biochemical screening for Down's syndrome.
- 26 June 1993
- Vol. 306 (6894), 1705-1706
- https://doi.org/10.1136/bmj.306.6894.1705
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsPrenatal Diagnosis, 1993
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- The extent of Down's syndrome screening in Britain in 1991The Lancet, 1992
- First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.BMJ, 1992
- Free β-hCG as first-trimester marker for fetal trisomyThe Lancet, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984